Healthcare Services

Calciphylaxis Treatment Market Growth Expected to Reach $3.02 Billion by 2030 with 8.3% CAGR

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Calciphylaxis Treatment Market During The Forecast Period 2026–2030?

The calciphylaxis treatment market has demonstrated strong growth in recent years. It is anticipated to increase from $2.03 billion in 2025 to $2.2 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.4%. The expansion observed historically can be credited to an enhanced understanding of calciphylaxis pathology, a higher rate of diagnosis among ESRD patients, the availability of supportive pharmacological treatments, the expansion of hospital-based treatment protocols, and escalating clinical research initiatives.

The calciphylaxis treatment market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $3.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period is driven by several factors, including the escalating development of targeted drug therapies, the growing embrace of combination treatment methods, the proliferation of specialized centers for calciphylaxis treatment, increased financial commitment to rare disease therapeutics, and a heightened emphasis on enhancing patient survival rates. Key trends projected for the forecast period encompass a greater prevalence of sodium thiosulfate therapy, a surge in the adoption of hyperbaric oxygen treatment, an intensified focus on managing the disease through multidisciplinary teams, the expansion of advanced wound care solutions, and a stronger emphasis on timely therapeutic interventions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13394&type=smp

What Drivers Are Expected To Influence The Calciphylaxis Treatment Market During The Forecast Period?

The anticipated expansion of the calciphylaxis treatment market is expected to be propelled by the rising occurrence of kidney diseases in the future. Kidney diseases encompass a broad spectrum of medical conditions and disorders impacting the kidneys, which are crucial organs for filtering waste products and excess fluids from the bloodstream to form urine. These conditions disrupt calcium and phosphate metabolism, thereby elevating the risk of calciphylaxis and making it necessary to develop effective diagnostic and treatment strategies. For instance, in June 2023, Kidney Research UK, a UK-based charitable organization, reported that approximately 7.19 million people in the UK were affected by chronic kidney disease in 2023, accounting for over 10% of the UK population, a number projected to increase to 7.61 million people by 2033. Consequently, the increasing prevalence of kidney diseases will be a significant factor driving the growth of the calciphylaxis treatment market.

What Market Segments Are Evaluated Within The Calciphylaxis Treatment Market?

The calciphylaxis treatment market covered in this report is segmented –

1) By Type: Medication, Hyperbaric Oxygen Therapy, Other Types

2) By Diagnosis: Imaging, Blood Tests

3) By End User: Hospitals, Clinics, Medical Research Centers

Subsegments:

1) By Medication: Sodium Thiosulfate, Bisphosphonates, Cinacalcet

2) By Hyperbaric Oxygen Therapy: Monoplace Hyperbaric Oxygen Therapy, Multiplace Hyperbaric Oxygen Therapy

3) By Other Types: Dialysis, Wound Care And Management

How Are Trends Impacting The Calciphylaxis Treatment Market?

Major companies operating in the calciphylaxis treatment market are developing advanced diagnostic techniques and health evaluation kits and services, such as the deployment of in-home chronic kidney disease diagnostic and preventive services, to enhance early detection and patient-centric care outcomes. The implementation of in-home chronic kidney disease diagnostic and preventive services refers to a structured program designed to provide kidney health assessment, early identification of chronic kidney disease, and preventive healthcare interventions directly at patients’ homes, aiming to improve patient outcomes, increase accessibility to diagnostics, and reduce the burden on traditional healthcare facilities. For instance, in August 2023, Signify Health, Inc., a US-based healthcare company, launched a comprehensive in-home kidney health evaluation as an addition to its diagnostic and preventive services, aimed at aiding in the early detection, diagnosis, and management of chronic kidney health issues. These in-home health assessments and kidney evaluations include urinalysis (uACR) and an estimated glomerular filtration rate (eGFR), providing crucial information for treatment options such as additional tests, lifestyle changes, medication, or referral to a nephrologist. This service is especially advantageous for illnesses such as calciphylaxis, a rare disorder characterized by calcium deposits in tiny arteries associated with end-stage renal failure, allowing for early identification and treatment.

Who Are The Top Market Participants Influencing The Calciphylaxis Treatment Market?

Major companies operating in the calciphylaxis treatment market are Pfizer Inc., Merck And Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Sanofi SA, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Novo Nordisk, Viatris, Regeneron Pharmaceuticals Inc., Incyte Corporation, Vifor Pharma Group, Panion And BF Biotech Inc., Inozyme Pharma Inc., Sanifit Therapeutics S.A., Hope Pharmaceuticals, Menlo Therapeutics

Read the full calciphylaxis treatment market report here:

https://www.thebusinessresearchcompany.com/report/calciphylaxis-treatment-global-market-report

Which Region Is Forecast To Lead The Calciphylaxis Treatment Market In Terms Of Market Size?

North America was the largest region in the calciphylaxis treatment market in 2025 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Calciphylaxis Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13394&type=smp

Browse Through More Reports Similar to the Global Calciphylaxis Treatment Market 2026, By The Business Research Company

Calcium Aluminosilicate Global Market Report

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Cephalosporin Global Market Report

https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

Xylitol Global Market Report

https://www.thebusinessresearchcompany.com/report/xylitol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795